Comparative topical delivery of antifungal drug croconazole using liposome and micro-emulsion-based gel formulations

Drug Delivery

Volumn 21, Issue 1, 2014, Pages 34-43

  El Badry, Mahmoud ^a,b   Fetih, Gihan ^b   Shakeel, Faiyaz ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Assiut University   (Egypt)

Author keywords

Antifungal activity; Croconazole; Liposomes; Micro emulsion; Topical delivery

Indexed keywords

ALCOHOL; CARBOMER; CARBOXYMETHYLCELLULOSE; CELLOPHANE; CHITOSAN; COSURFACTANT; CROCONAZOLE; EUCALYPTUS OIL; LIPOSOME; MICONAZOLE; POLOXAMER; POLYSORBATE 80; PROPYLENE GLYCOL;

ANIMAL EXPERIMENT; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SAFETY; DRUG SOLUBILITY; ENCAPSULATION; GEL; IN VITRO STUDY; MALE; MEMBRANE PERMEABILITY; MICROBIAL ACTIVITY; MICROEMULSION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SKINFOLD THICKNESS; STRATUM CORNEUM; VISCOSITY; ZETA POTENTIAL;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIFUNGAL AGENTS; DRUG DELIVERY SYSTEMS; EMULSIONS; FUNGI; GELS; IMIDAZOLES; LIPOSOMES; MALE; MEMBRANES, ARTIFICIAL; MICONAZOLE; MICROBIAL SENSITIVITY TESTS; PARTICLE SIZE; POLYMERS; RATS; RATS, WISTAR; SKIN; SKIN ABSORPTION;

EID: 84892185387     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2013.843610     Document Type: Article

References (43)

1. Aggarwal N, Goindi S. (2012). Preparation and evaluation of antifungal efficacy of griseofulvin loaded deformable membrane vesicles in optimized guinea pig model of Microsporum canis-dermatophytosis. Int J Pharm 437:277-87.
2. Aggarwal N, Goindi S, Khurana R. (2013). Formulation, characterization and evaluation of an optimized microemulsion formulation of griseofulvin for topical application. Coll Surf B 105:158-66.
3. Ahmed M, Ramadan W, Shakeel F. (2008). Potential of nanoemulsions for intravenous delivery of rifampicin. Pharmazie 63:806-11.
4. Al-Suwayeh SA. (2003). Transdermal delivery of isoradipine through excised rabbit skin effect of vehicle and drug concentration. Saudi Pharm J 11:46-52.
5. Bachhav YG, Patravale VB. (2009). Microemulsions based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation. Int J Pharm 365:175-9.
6. Boinpally RR, Zhou S, Poondru S, et al. (2003). Lecithin vesicles for topical delivery of diclofenac. Eur J Pharm Biopharm 56:389-92.
7. Bonina FP, Montenegro L. (1994). Vehicle effects on in vitro heparin release and skin penetration from different gels. Int J Pharm 102: 19-24.
8. Carafa M, Santucci E, Lucania G. (2002). Lidocaine-loaded non-ionic surfactant vesicles: characterization and in vitro permeation studies. Int J Pharm 231:21-32.
9. Choi HG, Oh YK, Kim CK. (1998). In situ gelling and mucoadhesive liquid suppository containing acetaminophen: enhanced bioavailability. Int J Pharm 165:23-32.
10. Cooney GF, Jeevanadam V, Choudhury S, et al. (1998). Comparative bioavailability of neoral and sandimmune in cardiac transplantation recipients over one year. Transplant Proc 30:1892-4.
11. De-Lucca AJ, Walsh TJ. (1999). Antifungal peptides: novel therapeutic compound against emerging pathogens. Antimic Agents Chemother 43:1-41.
12. Eccleston J. (1994). Microemulsions. In: Swarbrick J, Boylan JC, eds. Encyclopedia of pharmaceutical technology. New York: Marcel Dekker, Vol. 9, pp. 375-421.
13. El-Badry M. (2007). Liposomal gel of diclofenac sodium as topical delivery system. Bull Pharm Sci Assiut Uni 30:159-67.
14. El-Badry M, Fetih G. (2011). Preparation, characterization and antiinflammatory activity of celecoxib chitosan gel formulations. J Drug Del Sci Technol 21:201-6.
15. El-Maghraby GM. (2008). Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: effect of cosurfactant. Int J Pharm 355: 285-92.
16. Fauvel M, Farrugia C, Tsapis N, et al. (2012). Aerosolized liposomal amphotericin B: prediction of lung deposition, in vitro uptake and cytotoxicity. Int J Pharm 436:106-10.
17. Foco A, Gasperlin M, Kristl J. (2005). Investigation of liposomes as carrier of sodium ascorbyl phosphate for cutaneous photoprotection. Int J Pharm 291:21-9.
18. French DL, Haglund BO, Himmelstein KJ, et al. (1995). Controlled release of substituted benzoic and naphthoic acids using carbopol gels: measurement of drug concentration profiles and correlation to release rate kinetics. Pharm Res 12:1513-20.
19. Fromtling RA. (1988). Overview of medically important antifungal azole derivatives. Clin Microbiol Rev 1:187-217.
20. Hirano E, Morimoto K, Takeeda T, et al. (1980). Pharmaceutical studies of polyacrylic acid aqueous gel bases. II. absorption of ibuprofen from gel preparations following rectal administration in rats. Chem Pharm Bull 28:3521-6.
21. Kim CK, Ryuu SA, Park KM, et al. (1997). Preparation and physicochemical characterization of phase inverted water/oil microemulsion containing cyclosporine A. Int J Pharm 147:131-4.
22. Klich CM. (1992). Jels and jellies. In: Swarbrick J, Boylan JC, eds. Encyclopedia of pharmaceutical technology, Vol. 16.New York, NY: Marcel Dekker, 415-39.
23. Mezei M. (1992). Biodisposition of liposome-encapsulated active ingredients applied on the skin. In: Braun-Falco O, Korting HC, Maibach HI, eds. Liposome dermatics. Berlin: Springer-Verlag, 206-14.
24. Monforte V, Ussetti P, Gavalda J, et al. (2010). Feasibility, tolerability and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation. J Heart Lung Trans 29: 523-30.
25. Nesseem DI. (2001). Formulation and evaluation of itraconazole via liquid crystal for topical delivery system. J Pharm Biomed Anal 26: 387-99.
26. Ogata M, Matsumoto H, Hamada Y, et al. (1983). 1-[1-[2-[(3- chlorobenzyl) oxy] phenyl] vinyl]-1H-imidazole hydrochloride, a new potent antifungal agent. J Med Chem 26:768-70.
27. Park YJ, Yong CS, Kim HM, et al. (2003). Effect of sodium chloride on the release, absorption and safety of diclofenac sodium delivered by poloxamer gel. Int J Pharm 263:105-11.
28. Peira L, Carlotti ME, Trotta C, et al. (2008). Positively charged microemulsions for topical application. Int J Pharm 346:119-23.
29. Peltola H, Saarinen-Savolainen P, Kiesvaara J, et al. (2003). Microemulsions for topical delivery of estradiol. Int J Pharm 254: 99-107.
30. Pestana KC, Formariz TP, Franzini CM, et al. (2008). Oil-in-water lecithin-based microemulsions as a potential delivery system for amphotericin B. Coll Surf B 66:253-9.
31. Pinnaduwage P, Bruce BD. (1996). In vitro interaction between a chloroplast transit peptide and chloroplast outer envelope lipids is sequence-specific and lipid class-dependent. J Biol Chem 51: 32907-15.
32. Reineck J. (1998). Topische Zuberitungen mit Croconazol und Vitamin A saure auf der Basis von Nanoemulsionen und Liposomen [PhD dissertation]. Germany: Freiburg University.
33. Rubio MC, Rezusta A, Gil-Tomas J, et al. (1999). Mycological view of dermatophytes in human. Rev Iberoam Micol 16:16-22.
34. Schmolka IR. (1972). Artificial skin I. preparation and properties of pluronic F-127 gels for treatment of burns. J Biomed Matter Res Part A 6:571-82.
35. Shakeel F, Haq N, Elbadry M, et al. (2013). Ultra fine super selfnanoemulsifying drug delivery system (SNEDDS) enhanced solubility and dissolution of indomethacin. J Mol Liq 180:89-94.
36. Shakeel F, Shafiq S, Haq N, et al. (2012). Nanoemulsions as potential vehicles for transdermal and dermal delivery of hydrophobic compounds: an overview. Expert Opin Drug Deliv 9: 953-74.
37. Sheikh S, Ali SM, Ahmad MU, et al. (2010). Nanosomal amphotericin B is an efficacious alternative to Ambisome for fungal therapy. Int J Pharm 397:103-8.
38. Singh R, Ahmida NHS, Shakeel F. (2010). Antimicrobial activity of essential oils of Juniperus communis against bacterial and fungal species. Int J Essen Oil Ther 4:92-4.
39. Spiewak R. (2000). Patch tests with popular topical antifungal drugs in eczema patients. Int Rev Allergol Clin Immunol 6:136-8.
40. Thesen R. (1995). Croconazol, ein neues Antimykotikum. Pharm Zeitung 30:1120-1.
41. Varshosaz J, Tabbakhian M, Salmani Z. (2008). Design of a thermosensitive chitosan/poloxamer in situ gel for ocular delivery of ciprofloxacin. Open Drug Del J 2:61-70.
42. Walters KA, Roberts MS. (1993). Veterinary applications of skin penetration enhancers. In: Walters KA, Hadgraft J, eds. Pharmaceutical skin penetration enhancement. New York, NY: Marcel Dekker, pp. 345-64.
43. Were LM, Bruce BD, Davidson PM, et al. (2003). Size, stability and entrapment efficiency of phospholipid nanocapsules containing polypeptide antimicrobials. J Agr Food Chem 512:8076-9.